Olivier Millet

About Olivier Millet

Olivier Millet is a well-known French and European private equity executive, long associated with Eurazeo and the development of its mid-cap investment platform. Until 2025, he led the investment activity dedicated to small and medium-sized companies, while also overseeing the development of the Group’s Healthcare activity. He also supported the management of Kurma Partners, Eurazeo’s asset management company focused on biotechnology and medical innovation. In March 2025, Eurazeo confirmed that he stepped down from the Executive Board as part of a carefully managed leadership transition. His career reflects deep expertise in private equity, growth investing, and the scaling of investment platforms. Olivier Millet began his career in 1986 by founding Capital Finance. He then spent 11 years at Barclays Private Equity France, contributing to the development of a pan-European fund. Later, he served as Chairman of the Executive Board of OFI Private Equity, a listed investment company that became Eurazeo PME in 2011. This progression gave him extensive experience in supporting entrepreneurs, structuring growth capital transactions, and creating long-term value in the SME and mid-cap segments. At Eurazeo, Olivier Millet played a central role in building one of Europe’s most recognized mid-market franchises. Under his leadership, the SMBO strategy evolved from a balance-sheet-funded model into an asset management model, with a significant rise in assets under management, accelerated European expansion, and top-tier performance on recent funds. Eurazeo also highlights his contribution to healthcare investing, his commitment to ESG principles, and his role in broadening the Group’s investor base and offering. Beyond Eurazeo, he held important industry roles as Vice Chairman of AFIC from 2014 to 2016 and Chairman of France Invest from 2016 to 2018, reinforcing his influence in the French private equity ecosystem.